Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q1 2023 Earnings Call Transcript May 10, 2023
Syros Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.85, expectations were $-1.09.
Operator: Good morning, and welcome to Syros Pharmaceuticals’ First Quarter 2023 Financial Results Conference Call. [Operator Instructions]. This call is being webcast live on the Investors and Media section of Syros’ website at www.syros.com. Please be advised that today’s call is being recorded. At...
